Xylyx Bio

Xylyx Bio, Inc. is a commercial-stage biotechnology company developing breakthrough technologies related to the cellular microenvironment, with a focus on fibrosis, scarring, and skin health. It is advancing an anti-fibrotic drug testing platform, which will help scientists discover and test candidate drugs for idiopathic pulmonary fibrosis (IPF).